<Record>
<Term>Loracarbef</Term>
<SemanticType>Pharmacologic Substance</SemanticType>
<SemanticType>Organic Chemical</SemanticType>
<ParentTerm>Cephalosporin Antibiotic</ParentTerm>
<ClassificationPath>Chemicals_and_Drugs_Kind/Drug, Food, Chemical or Biomedical Material/Pharmacologic Substance/Anti-Infective Agent/Antibiotic/Cephalosporin Antibiotic/Loracarbef</ClassificationPath>
<ClassificationPath>Chemicals_and_Drugs_Kind/Drug, Food, Chemical or Biomedical Material/Pharmacologic Substance/Anti-Infective Agent/Antibiotic/Cephalosporin Antibiotic/Loracarbef Anhydrous</ClassificationPath>
<BroaderTerm>Chemicals_and_Drugs_Kind</BroaderTerm>
<BroaderTerm>Antibiotic</BroaderTerm>
<BroaderTerm>Loracarbef</BroaderTerm>
<BroaderTerm>Cephalosporin Antibiotic</BroaderTerm>
<BroaderTerm>Pharmacologic Substance</BroaderTerm>
<BroaderTerm>Loracarbef Anhydrous</BroaderTerm>
<BroaderTerm>Anti-Infective Agent</BroaderTerm>
<BroaderTerm>Drug, Food, Chemical or Biomedical Material</BroaderTerm>
<Synonym>Loracarbef</Synonym>
<Synonym>(6R, 7S)-7-[(R)-2-Amino-2-phenylacetamido]-3-chloro-8-oxo-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic Acid, Monohydrate</Synonym>
<Synonym>Loracarbef Anhydrous</Synonym>
<Synonym>LORACARBEF, ANHYDROUS</Synonym>
<Synonym>LORACARBEF</Synonym>
<Synonym>Lorabid</Synonym>
<Description>A semi-synthetic, broad-spectrum, beta-lactamase resistant, second-generation cephalosporin antibiotic derived from cephasporium. The bactericidal activity of loracarbef results from the inhibition of bacterial cell wall synthesis through interference with the cross-linking of peptidoglycan units. This results in a reduction of cell wall stability and causes cell lysis. Loracarbef is more active against a variety of gram-negative organisms but less active against gram-positive pathogens compared to first-generation agents.</Description>
<Source>FDA Registry</Source>
<Source>NCI Thesaurus</Source>
</Record>
